Adult Burkitt leukemia and lymphomaBLUM, Kristie A; LOZANSKI, Gerard; BYRD, John C et al.Blood. 2004, Vol 104, Num 10, pp 3009-3020, issn 0006-4971, 12 p.Article

Antibodies for the treatment of diffuse large cell lymphomaBLUM, Kristie A; BARTLETT, Nancy L.Seminars in oncology. 2003, Vol 30, Num 4, pp 448-456, issn 0093-7754, 9 p.Article

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765HERMAN, Sarah E. M; GORDON, Amber L; HAMDY, Ahmed et al.Blood. 2011, Vol 117, Num 23, pp 6287-6296, issn 0006-4971, 10 p.Article

Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human PlasmaQING LIU; FARLEY, Katherine L; PHELPS, Mitch A et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 620-627, issn 0163-4356, 8 p.Article

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002RIZZIERI, David A; JOHNSON, Jeffrey L; LARSON, Richard A et al.British journal of haematology. 2014, Vol 165, Num 1, pp 102-111, issn 0007-1048, 10 p.Article

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor IbrutinibWOYACH, Jennifer A; FURMAN, Richard R; DAVE, Sandeep S et al.The New England journal of medicine. 2014, Vol 370, Num 24, pp 2286-2294, issn 0028-4793, 9 p.Article

A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with FlavopiridolJIA JI; MOULD, Diane R; BLUM, Kristie A et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1269-1280, issn 1078-0432, 12 p.Article

The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemiaHERMAN, Sarah E. M; LAPALOMBELLA, Rosa; BYRD, John C et al.Blood. 2011, Vol 117, Num 16, pp 4323-4327, issn 0006-4971, 5 p.Article

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaBYRD, John C; FURMAN, Richard R; JONES, Jeffrey A et al.The New England journal of medicine. 2013, Vol 369, Num 1, pp 32-42, issn 0028-4793, 11 p.Article

Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationBLUM, Kristie A; ZHONGFA LIU; FLYNN, Joseph et al.British journal of haematology. 2010, Vol 150, Num 2, pp 189-195, issn 0007-1048, 7 p.Article

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemiaPHELPS, Mitch A; LIN, Thomas S; MORAN, Mollie E et al.Blood. 2009, Vol 113, Num 12, pp 2637-2645, issn 0006-4971, 9 p.Article

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolMAHONEY, Emilia; LUCAS, David M; BLUM, Kristie A et al.Blood. 2012, Vol 120, Num 6, pp 1262-1273, issn 0006-4971, 12 p.Article

Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative DisordersLIN, Thomas S; BLUM, Kristie A; SCHAAF, Larry J et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 418-423, issn 0732-183X, 6 p.Article

Development and validation of a rapid and sensitive high-performance liquid chromatography-mass spectroscopy assay for determination of 17-(allylamino)-17-demethoxygeldanamycin and 17-(amino)-17-demethoxygeldanamycin in human plasmaJOHNSTON, Jeffrey S; PHELPS, Mitch A; BLUM, Kristie A et al.Journal of chromatography. B. 2008, Vol 871, Num 1, pp 15-21, issn 1570-0232, 7 p.Article

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemiaBYRD, John C; LIN, Thomas S; BROERING, Sarah et al.Blood. 2007, Vol 109, Num 2, pp 399-404, issn 0006-4971, 6 p.Article

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent LymphomaGOPAL, Ajay K; KAHL, Brad S; BLUM, Kristie A et al.The New England journal of medicine. 2014, Vol 370, Num 11, pp 1008-1018, issn 0028-4793, 11 p.Article

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphomaFEHNIGER, Todd A; LARSON, Sarah; KEPPEL, Catherine R et al.Blood. 2011, Vol 118, Num 19, pp 5119-5125, issn 0006-4971, 7 p.Article

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell deathALINARI, Lapo; MAHONEY, Emilia; TOWNS, William H et al.Blood. 2011, Vol 118, Num 26, pp 6893-6903, issn 0006-4971, 11 p.Article

Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive diseaseWOYACH, Jennifer A; HEEREMA, Nyla A; BYRD, John C et al.British journal of haematology. 2010, Vol 148, Num 5, pp 754-759, issn 0007-1048, 6 p.Article

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-hodgkin lymphoma : Results of cancer and leukemia group B study 9153BLUM, Kristie A; JOHNSON, Jeffrey L; NIEDZWIECKI, Donna et al.Cancer. 2006, Vol 107, Num 12, pp 2817-2825, issn 0008-543X, 9 p.Article

Complete Response to Induction Therapy in Patients With Myc-Positive and Double-Hit Non-Hodgkin Lymphoma Is Associated With Prolonged Progression-Free SurvivalCOHEN, Jonathon B; GEYER, Susan M; CHRISTIAN, Beth A et al.Cancer. 2014, Vol 120, Num 11, pp 1677-1685, issn 0008-543X, 9 p.Article

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)GORDON, Leo I; FANGXIN HONG; ADVANI, Ranjana et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 684-691, issn 0732-183X, 8 p.Article

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell LymphomaWANG, Michael L; RULE, Simon; BARRIENTOS, Jacqueline C et al.The New England journal of medicine. 2013, Vol 369, Num 6, pp 507-516, issn 0028-4793, 10 p.Article

Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter AnalysisEVENS, Andrew M; ADVANI, Ranjana; KROLL-DESROSIERS, Aimee et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4132-4139, issn 0732-183X, 8 p.Conference Paper

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular LymphomaBAIOCCHI, Robert A; ALINARI, Lapo; LUSTBERG, Mark E et al.Cancer. 2011, Vol 117, Num 11, pp 2442-2451, issn 0008-543X, 10 p.Article